The first CLOCS project showed that ovarian cancer patients started buying over-the-counter medications up to 8 or 9 months before their diagnosis, with their first GP visit regarding their symptoms ...

The most promising of these rapid horizon-scanning analyses often develop into an in-depth research project. You can find policy briefings for these with their related reports on the publications page ...

The European Union introduced the General Data Protection Regulation (GDPR) in 2018 and it forms part of current UK law. A long and complex piece of legislation, the GDPR governs the processing of ...

Transcriptomics is the analysis of the transcriptome, the collection of all ribonucleic acid (RNA) that is present in a sample (a cell, tissue or organ) at a given time. RNA performs many functions ...

Advances in clinical genomics have been enabled by short-read sequencing (SRS) technologies, where the DNA is broken into pieces up to 300 base pairs long. While these technologies have many ...

A series of reports each examining a different aspect of the problem of human interpretability of machine learning in healthcare and research. In clarifying the requirements for transparency and ...

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum consequat felis eu elit facilisis, sed posuere magna suscipit. Fusce urna elit, placerat quis blandit quis, mattis id ipsum. Vivamus ...

The potential of polygenic scores to improve risk stratification has reignited enthusiasm around the use of genetic information to help predict and prevent common disease. A new report from the PHG ...

Visual identifiers in the care of people with dementia, addresses the ethical and legal issues affecting the use of visual identifiers in hospitals, exploring issues such as patient autonomy, consent, ...

Chantal is a Senior Policy Analyst contributing to many of PHG foundations projects including B-CAST, polygenic scores and Innovative Science. As a senior analyst she supports the science team in ...

Synthetic data—artificial data that closely mimic the properties and relationships of real data—are not a new concept but technological advances have led to great optimism about their potential for ...

In Artificial intelligence for genomic medicine we examine the intersection between AI and genomics, the drivers behind the recent rise of AI techniques for genomics and outline existing and emerging ...